Program Overview
This virtual seminar will feature a multidisciplinary panelist of heart failure experts discussing the challenges and opportunities with implementing the updated Guideline-Directed Medical Therapy (GDMT). Attendees will be presented with case study vignettes that will drive meaningful and engaging discussions. Conversations amongst the panelist include how to navigate cost and availability of medication, and how the new value statements may help to support and inform patient engagement.
The original recording date was on August 25, 2022 and will expire on August 25, 2023.
Target Audience
This program is intended for physicians, nurses, nurse practitioners, pharmacists, and advanced practice professionals that provide care to patients with heart failure.
Learning Objectives
At the conclusion of this activity, learners will be better able to:
1. Explain the updated heart failure guidelines
2. Weigh pharmaceutical costs when promoting access to care
3. Utilize resources to begin new therapies in a team-based model
Program Planners
Jennifer Cook, MD – University of Cincinnati, OH
Eileen Hsich, MD, FHFSA – Cleveland Clinic, OH
Theresa Diederich, NP, FHFSA – Nebraska Medicine, NE
Tien Ng, PharmD, FHFSA – University of Southern California, CA
Moderators
Jennifer Cook, MD – University of Cincinnati, OH
Fellow/Early Career: Vanessa Blumer, MD – Cleveland Clinic, OH
Panelists
Theresa Diederich, NP, FHFSA – Nebraska Medicine, NE
Eileen Hsich, MD, FHFSA – Cleveland Clinic, OH
Michelle Kittleson, MD, PhD, FHFSA – Cedars Sinai, CA
Tien Ng, PharmD, FHFSA – University of Southern California, CA
Andrew J. Sauer, MD – Saint Luke's Mid America Heart Institute, KS
Agenda
- Welcome
- Communication Challenges
- New Onset of HF
- SGLT2 HfpEF
- Closing Remarks